Radiofrequency denervation for low back pain

2021 ◽  
Author(s):  
Kate Ashton ◽  
Vikki Wylde
2007 ◽  
Vol 2;10 (3;2) ◽  
pp. 291-299
Author(s):  
Michael Gofeld

Background: Evidence for the efficacy of zygapophysial joint nerve radiofrequency neurotomy has remained controversial. Two randomized controlled trials showed positive results, but two others demonstrated no benefit. One carefully performed prospective trial confirmed high efficacy and lasting pain relief after the procedure; however, selection criteria for this study were superfluous, which resulted in a small number of patients available for follow up. Objectives: A large clinical audit with routine patient selection and use of appropriate technique was undertaken to determine the effect of radiofrequency neurotomy of the lumbar facet joints for relief of chronic low back pain. Design: Prospective clinical audit for quality was conducted in the pain clinic affiliated with a tertiary care teaching hospital. Setting: An interventional pain management setting in Canada. Methods: All patients with low back pain of more than 6 months’ duration, with or without non-radicular radiation to the buttock, hip, and leg were included. From January 1991 to December 2000, eligible patients underwent standardized diagnostic work-up, which included a self-reported pain questionnaire, physical examination, review of imaging studies, and diagnostic blockades. Those with an appropriate response to comparative double diagnostic blocks underwent standardized radiofrequency denervation of the lumbar zygapophysial joints. Patients were asked to estimate total perceived pain reduction (on a scale from 0% to 100%) at 6 weeks and at 6, 12, and 24 months after the procedure. Results: Of the 209 patients, 174 completed the study, and 35 were lost to follow-up or did not provide complete data for assessment. Of the 174 patients with complete data, 55 (31.6%) experienced no benefit from the procedure. One hundred and nineteen patients (68.4%) had good (> 50%) to excellent (> 80%) pain relief lasting from 6 to 24 months. Conclusion: This large, prospective clinical audit indicates that proper patient selection and anatomically correct radiofrequency denervation of the lumbar zygapophysial joints provide long-term pain relief in a routine clinical setting. Key words: low back pain, lumbar zygapophysial joint, radiofrequency denervation, clinical audit


JAMA ◽  
2017 ◽  
Vol 318 (22) ◽  
pp. 2256 ◽  
Author(s):  
Ming-Chih Kao ◽  
Michael S. Leong ◽  
Sean Mackey

Author(s):  
Leena Niemisto ◽  
Jukkapekka Jousimaa ◽  
Heikki Hurri ◽  
Eija A Kalso ◽  
Antti Malmivaara

2019 ◽  
Vol 45 (1) ◽  
pp. 79-83 ◽  
Author(s):  
William L Lanier ◽  
Joseph M Neal

In 2017, JAMA: Journal of the American Medical Association published the results of the MINT trials, prospective research involving 681 patients, all of whom received exercise therapy for low back pain. Half of the patients were randomized to additionally receive radiofrequency denervation (RFD) treatment. 88% of patients completed the 3-month follow-up, and 77% completed the 12-month follow-up. In this context, RFD provided no added benefit over the baseline of exercise therapy. In 2018, five authors, all experts in pain medicine, published a ‘Daring Discourse’ article in the journal Regional Anesthesia and Pain Medicine (RAPM), criticizing the findings of the MINT trials. Although 3 of the 5 authors of the RAPM ‘Daring Discourse’ article reported in conflict of interest statements—as is appropriate—that they were consultants to corporations that produce RFD equipment, the authors failed to disclose that 4 of 5 are on the editorial board of RAPM and all 5 are current officers in the medical organization that owns RAPM: that is, the American Society of Regional Anesthesia and Pain Medicine. Noteworthy, there was no published response from the MINT trial investigators to the Daring Discourse criticisms, either in the aforementioned example or in downstream venues where some of the same Daring Discourse authors continued their widely disseminated criticisms of the JAMA/MINT trials report. We believe that these actions taken by the Daring Discourse authors and RAPM have unfairly tipped the scales in the evaluation and application of RFD treatment of low back pain. In our commentary, we discuss: (1) the challenges associated with using clinical trials to predict clinical efficacy, (2) appropriate and inappropriate uses of postpublication commentary on original research findings, (3) the use of inappropriate commentary (and related means) to alter clinical practice in the presence of contradictory research findings, and (4) potential conflicts of interest related to the authors’ and Journal’s publication of the unopposed MINT trials criticism.


Spine ◽  
2014 ◽  
Vol 39 (14) ◽  
pp. E842-E849 ◽  
Author(s):  
Arthur Werner Poetscher ◽  
Andre Felix Gentil ◽  
Mario Lenza ◽  
Mario Ferretti

2013 ◽  
Vol 117 (1) ◽  
pp. 228-235 ◽  
Author(s):  
Stefan Lakemeier ◽  
Marcel Lind ◽  
Wolfgang Schultz ◽  
Susanne Fuchs-Winkelmann ◽  
Nina Timmesfeld ◽  
...  

JAMA ◽  
2017 ◽  
Vol 318 (22) ◽  
pp. 2254 ◽  
Author(s):  
Yakov Vorobeychik ◽  
Milan P. Stojanovic ◽  
Zachary L. McCormick

Sign in / Sign up

Export Citation Format

Share Document